Insulet | PODD - Ordinary Share Capital


Insulet reported $69.26M in Ordinary Share Capital for its fiscal quarter ending in March of 2026.





Ordinary Share Capital Change Date
Abbott USD 1.74B 23.39B Sep/2025
Align Technology USD 71.62M 133K Mar/2026
AtriCure USD 49.79M 91K Dec/2025
Avanos Medical USD 46.67M 216.61K Mar/2026
Baxter International USD 516.45M 2.17M Mar/2026
Becton, Dickinson and Co. USD 284.91M 1.72M Dec/2025
Boston Scientific USD 1.48B 2.66M Dec/2025
Cardinal Health USD 235M 1000K Mar/2026
Cooper Companies USD 195.11M 14K Mar/2026
Dexcom USD 385.9M 1.1M Mar/2026
Edwards Lifesciences USD 580.7M 0 Dec/2025
Eli Lilly USD 943.5M 3.33M Mar/2026
Globus Medical USD 135.06M 449K Dec/2025
ICU Medical USD 24.69M 2K Dec/2025
Inogen USD 23K 0 Dec/2023
Insulet USD 69.26M 1.08M Mar/2026
Integra LifeSciences USD 77.82M 69K Mar/2026
J&J USD 2.41B 1.35M Mar/2026
Medtronic USD 1.28B 1.38M Dec/2025
Merit Medical Systems USD 59.65M 231K Mar/2026
Roche Holding CHF 795.62M 699.54K Dec/2025
Solventum Corp USD 173.53M 40.79K Mar/2026
Stryker USD 382.98M 584K Mar/2026
Tandem Diabetes Care USD 68.29M 518K Dec/2025
Teleflex USD 44.26M 70K Mar/2026
West Pharmaceutical Services USD 70.9M 1.1M Mar/2026
Zimmer Biomet Holdings USD 195.5M 2.68M Mar/2026